PDK4 and cancer: Thereby, in contrast to former studies mainly focusing on PDK4 expression in cancer cells per se, our data consistently suggest that PDK4 induction in the tumor stroma may represent an SASP-associated independent predictor of clinical prognosis, holding the potential to be exploited for stratifying the risk of disease relapse and clinical mortality.